Monday, December 30, 2019

AstraZeneca, Merck score win with Lynparza approval for pancreatic cancer

AstraZeneca, Merck score win with Lynparza approval for pancreatic cancer The drug is now the only approved medicine in biomarker-selected patients with advanced pancreatic cancer.

from Moneycontrol Business News https://ift.tt/35awRrv

No comments:

Post a Comment

Oil Price Today (March 25): Oil slips below $100 on rising hopes of Iran war ceasefire. Here’s what experts are saying

Oil prices saw a significant drop as hopes for a ceasefire in the Middle East grew. Reports suggested a U.S. proposal aimed at ending the co...